Trials (Instituto Português de Oncologia do Porto Francisco Gentil): Revision history

15 December 2025

• curprev 13:3113:31, 15 December 2025‎ Francine talk contribs‎ 42,683 bytes +203‎ No edit summary undo

6 December 2025

• curprev 12:4112:41, 6 December 2025‎ Lucas talk contribs‎ m 42,480 bytes +1,701‎ Update categories. undo

4 December 2025

• curprev 15:2115:21, 4 December 2025‎ Larysse talk contribs‎ 40,779 bytes +50‎ No edit summary undo

2 December 2025

• curprev 13:5913:59, 2 December 2025‎ Lucas talk contribs‎ m 40,729 bytes +90‎ Update categories. undo

5 December 2023

• curprev 13:0413:04, 5 December 2023‎ Francine talk contribs‎ 40,639 bytes +40,639‎ Created page with "{{forpatients}} {{forresearchers}} {{forproviders}} Go back to Instituto Português de Oncologia do Porto Francisco Gentil page '''NCTID''': NCT02500043 '''Title''': Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer '''Study Summary''': The purpose of this trial is to compare the effects of TAS-102 and best supportive care (BSC) with Placebo (an inactive drug) and best supportive care on metastatic gastric cancer. '''Sponsor''': T..."